Study Findings from National Cancer Institute (NCI) Provide New Insights into Central Nervous System Disorders [Transcription Factor Egr2 Controls Homing and Pathogenicity of T(H)17 Cells In the Central Nervous System].

(Nature Publishing Group - www.nature.com/; Nature Immunology - www.nature.com/ni/) The news correspondents report that additional information may be obtained from Vanja Lazarevic, National Cancer Institute (NCI), Experimental Immunology Branch, National Institutes of Health (NIH), Bethesda, MD 20892, United States. Keywords: Bethesda; State:Maryland; United States; North and Central America; Central Nervous System; Central Nervous System Disorders; Genetics; Health and Medicine; Immunology; Neuroinflammation; Neurology; Proteins; Transcription Factors EN Bethesda State:Maryland United States North and Central America Central Nervous System Central Nervous System Disorders Genetics Health and Medicine Immunology Neuroinflammation Neurology Proteins Transcription Factors 2004 2004 1 08/14/23 20230818 NES 230818 2023 AUG 18 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Investigators publish new report on Neurology - Central Nervous System Disorders. [Extracted from the article]

Copyright of Genomics & Genetics Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)